Demystifying Continued Pharmacologic Therapy in HFrEF – Pivotal Opportunities to Improve Patient Outcomes - a podcast by ReachMD

Recent guideline updates and publications are leading to changes in care in patients with heart failure with reduced ejection fraction (HFrEF). What clinical evidence is driving recent changes to guideline directed medical therapy (GDMT) in HFrEF, and what real-world data exists that may impact the landscape of care and patient outcomes?

Join Drs. Piña, Butler, Fonarow, and Rosano for a lively discussion on the evolving role of precision medicine in HFrEF, including key pivotal situations of care that surround GDMT initiation, management, optimal dosing, and common morbidities.